» Articles » PMID: 33461503

Dynamic Changes in Lymphocyte Subsets and Parallel Cytokine Levels in Patients with Severe and Critical COVID-19

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2021 Jan 19
PMID 33461503
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The lack of knowledge regarding the pathogenesis and host immune response during SARS-CoV-2 infection has limited the development of effective treatments. Thus, we longitudinally investigated the dynamic changes in peripheral blood lymphocyte subsets and parallel changes in cytokine levels in COVID-19 patients with different disease severities to further address disease pathogenesis.

Methods: A total of 67 patients (10 moderate, 38 severe and 19 critical cases) with COVID-19 admitted to a tertiary care hospital in Wuhan from February 8th to April 6th, 2020 were retrospectively studied. Dynamic data of lymphocyte subsets and inflammatory cytokines were collected.

Results: On admission, compared with moderate cases, severe and critical cases showed significantly decreased levels of total lymphocytes, T lymphocytes, CD4 T cells, CD8 T cells, B cells and NK cells. IL-6 and IL-10 were significantly higher in the critical group. During the following hospitalization period, most of the lymphocyte subsets in the critical group began to recover to levels comparable to those in the severe group from the fourth week after illness onset, except for NK cells, which recovered after the sixth week. A sustained decrease in the lymphocyte subsets and an increase in IL-6 and IL-10 were observed in the nonsurvivors until death. There was a strong negative correlation between IL-6 and IL-10 and total lymphocytes, T lymphocytes, CD4 T cells, CD8 T cells and NK cells.

Conclusions: A sustained decrease in lymphocyte subsets, especially CD4 T cells and NK cells, interacting with proinflammatory cytokine storms was associated with severe disease and poor prognosis in COVID-19.

Citing Articles

Blood Inflammatory Markers and Cytokines in COVID-19 Patients With Bacterial Coinfections.

Bi Q, Zhu J, Zheng J, Xu Q, Chen J, Zhang L Immun Inflamm Dis. 2024; 12(12):e70105.

PMID: 39692539 PMC: 11653711. DOI: 10.1002/iid3.70105.


Dynamic Changes in Lymphocyte Populations and Their Relationship with Disease Severity and Outcome in COVID-19.

Andrejkovits A, Hutanu A, Manu D, Dobreanu M, Vasiesiu A Int J Mol Sci. 2024; 25(22).

PMID: 39595989 PMC: 11593669. DOI: 10.3390/ijms252211921.


Impact of diabetes mellitus on tuberculosis prevention, diagnosis, and treatment from an immunologic perspective.

Ye Z, Li L, Yang L, Zhuang L, Aspatwar A, Wang L Exploration (Beijing). 2024; 4(5):20230138.

PMID: 39439490 PMC: 11491313. DOI: 10.1002/EXP.20230138.


Contrasting mechanistic susceptibilities of hematopoietic and endothelial stem-progenitor cells in respective pathogeneses of HIV-1 and SARS-CoV-2 infections.

Koka P, Ramdass B Front Cell Dev Biol. 2023; 11:1296986.

PMID: 38155835 PMC: 10753180. DOI: 10.3389/fcell.2023.1296986.


Comparative analysis of clinical and immunological profiles across Omicron BA.5.2 subvariants using next-generation sequencing in a Chinese cohort.

Huang J, Xia M, Liu R, Wang S, Duan X, Peng J Front Cell Infect Microbiol. 2023; 13:1288914.

PMID: 37965255 PMC: 10642935. DOI: 10.3389/fcimb.2023.1288914.


References
1.
Wang F, Nie J, Wang H, Zhao Q, Xiong Y, Deng L . Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. J Infect Dis. 2020; 221(11):1762-1769. PMC: 7184346. DOI: 10.1093/infdis/jiaa150. View

2.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

3.
Altmann D, Boyton R . SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection. Sci Immunol. 2020; 5(49). DOI: 10.1126/sciimmunol.abd6160. View

4.
Salvarani C, Dolci G, Massari M, Merlo D, Cavuto S, Savoldi L . Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial. JAMA Intern Med. 2020; 181(1):24-31. PMC: 7577199. DOI: 10.1001/jamainternmed.2020.6615. View

5.
Lu Q, Wang Z, Yin Y, Zhao Y, Tao P, Zhong P . Association of Peripheral Lymphocyte and the Subset Levels With the Progression and Mortality of COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2020; 7:558545. PMC: 7546210. DOI: 10.3389/fmed.2020.558545. View